Imoro Zeba Braimah
Overview
Explore the profile of Imoro Zeba Braimah including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
68
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wagner S, Liefers B, Radia M, Zhang G, Struyven R, Faes L, et al.
Lancet Digit Health
. 2023 Apr;
5(6):e340-e349.
PMID: 37088692
Background: Retinopathy of prematurity (ROP), a leading cause of childhood blindness, is diagnosed through interval screening by paediatric ophthalmologists. However, improved survival of premature neonates coupled with a scarcity of...
2.
Braimah I, Amoaku W
Eye (Lond)
. 2022 May;
36(Suppl 1):40-44.
PMID: 35590054
Aim: To investigate the use of intravitreal ziv-aflibercept (IVZ) in Ghanaian patients with diabetic macular edema (DME). Methods: A retrospective study of patients with DME, who had been treated with...
3.
Mwangi N, Amissah-Arthur K, Braimah I, Sarfo-Kantanka O, Akpalu J, Akrofi B, et al.
Eye (Lond)
. 2022 May;
36(Suppl 1):12-16.
PMID: 35590050
Background: Diabetic retinopathy is a leading cause of blindness in many countries across the world. Ghana has seen a rise in diabetic retinopathy and is working on various strategies to...
4.
Braimah I, Agyabeng K, Amoaku W
Int Ophthalmol
. 2021 Mar;
41(7):2445-2453.
PMID: 33782846
Aim: To evaluate the efficacy of ziv-aflibercept in Ghanaian patients with macular edema (ME) secondary to retinal vein occlusion (RVO). Methodology: In this retrospective study, the medical records of patients...
5.
Braimah I, Enweronu-Laryea C, Sackey A, Kenu E, Agyabeng K, Ofori-Adjei I, et al.
BMJ Open
. 2020 Aug;
10(8):e035341.
PMID: 32759242
Objective: To determine the incidence of retinopathy of prematurity (ROP) and any associated risk factors among preterm infants at the Neonatal Intensive Care Unit (NICU) of Korle-Bu Teaching Hospital (KBTH)....
6.
7.
Singh S, Chattannavar G, Ayachit A, Pimentel M, Alfaro A, Tiwari S, et al.
Semin Ophthalmol
. 2019 Nov;
35(1):2-6.
PMID: 31690175
: To report the ocular and systemic adverse events in eyes receiving ≥10 intravitreal ziv-aflibercept (IVZ) injections.: Medical records of patients who received ≥10 IVZ for various chorioretinal conditions with...
8.
Braimah I, Kenu E, Amissah-Arthur K, Akafo S, Kwarteng K, Amoaku W
PLoS One
. 2019 Oct;
14(10):e0223944.
PMID: 31647843
Aim: To evaluate the safety of 1.25mg and 2mg intravitreal ziv-aflibercept (IVZ) in Ghanaian eyes with choroido-retinal vascular diseases. Design: Prospective, randomised, double blind, interventional study. Methods: Twenty patients with...
9.
Dave V, Pathengay A, Braimah I, Panchal B, Sharma S, Pappuru R, et al.
Retina
. 2019 Jan;
40(5):898-902.
PMID: 30681640
Purpose: To report the clinical presentation and management outcome of patients with endophthalmitis caused by Enterococcus species and to report the susceptibility profile of the isolates. Methods: Twenty-nine cases with...
10.
Singh S, Stewart M, Chattannavar G, Ashraf M, Souka A, ElDardeery M, et al.
Br J Ophthalmol
. 2018 Aug;
103(6):805-810.
PMID: 30099379
Purpose: To analyse the pooled safety data of intravitreal ziv-aflibercept (IVZ) therapy for various retinal conditions. Methods: This was a retrospective, observational study which included patients from 14 participating centres...